NCT06718816View on ClinicalTrials.gov

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

RecruitingOBSERVATIONAL

Enrollment

21

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions

Wet Age-related Macular Degeneration (wAMD)

Trial Locations (1)

Unknown

RECRUITING

Chinese Academy of Medical Sciences & Peking Union Hospital, Beijing

All Listed Sponsors

lead

Beijing Anlong Biopharmaceutical Co., Ltd.

INDUSTRY